Eucrates Biomedical Acquisition Corp.
(NASDAQ) EUCR
This security has been delisted. This page is retained for historical reference.
EUCR News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowEUCR Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
10%
Return on Capital
-6%
Return on Assets
44%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$699.00K
EBITDA
$2.58M
Operating Cash Flow
$630.29K
Capital Expenditure
$0.00
Free Cash Flow
$630.29K
Cash & ST Invst.
$18.86K
Total Debt
$60.06K
Eucrates Biomedical Acquisition Corp. Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$546.70K
-81.1%
EBITDA
$26.23K
-102.2%
Quarterly Fundamentals
Net Cash
$41.20K
-183.8%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
44.36%
N/A
Return on Invested Capital
-5.63%
N/A
Free Cash Flow
$391.18K
-17.1%
Operating Cash Flow
$391.18K
-17.1%